Keywords: speedel, highlights, teturna, potential, gold, standard, bp

Speedel highlights Teturna's potential as gold standard BP drug

Article | 28 May 2007

Print This

Swiss drugmaker Speedel says that new data from trials of its antihypertensive SPP100 (aliskiren, sold as Tekturna in the USA ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in